2.6. Co-Activation of JAK2-STAT3 and TrkA Pathways Is Associated with a Shortened Time to Develop Brain and Lung Metastasis of Triple-Negative and HER2-Enriched Breast Cancers. Here, ERBB2 is linked to breast carcinoma.